Faculty Opinions recommendation of Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13649956.15438060 ◽

2012 ◽

Author(s):

Paul Van Schil

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

Phase III Study Comparing Oral Topotecan to Intravenous Docetaxel in Patients With Pretreated Advanced Non–Small-Cell Lung Cancer

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70422-6 ◽

2007 ◽

Vol 2007 ◽

pp. 206-207

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study ◽

Download Full-text

Phase III study of vinflunine versus docetaxel in patients (pts) with advanced non-small cell lung cancer (NSCLC) previously treated with a platinum-containig regimen

Pneumologie ◽

10.1055/s-2008-1074239 ◽

2008 ◽

Vol 62 (S 2) ◽

Author(s):

J von Pawel ◽

M Reck ◽

R Ramlau ◽

J Jassem ◽

P Zatloukal ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study ◽

Previously Treated

Download Full-text

Faculty Opinions recommendation of Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1120004.586903 ◽

2008 ◽

Author(s):

Daniel Vorobiof ◽

Keo Tabane

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Advanced Stage ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

Reply to the article “Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study”, by Groen et al. (Ann Oncol 2004; 15: 427–432)

Annals of Oncology ◽

10.1093/annonc/mdh323 ◽

2004 ◽

Vol 15 (8) ◽

pp. 1298-1299

Author(s):

B. Jeremic

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Multicenter Phase ◽

Phase Iii Study

Download Full-text

Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone

Annals of Oncology ◽

10.1093/annonc/mdm061 ◽

2007 ◽

Vol 18 (5) ◽

pp. 903-908 ◽

Author(s):

S. Novello ◽

P. Bruzzi ◽

C. Barone ◽

R. Buosi ◽

A. Masotti ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Stage Iv ◽

Phase Iii ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Phase Iii Study

Download Full-text

C3-03: Randomized, phase III Study of mitomycin/vindesine/cisplatin (MVP) versus weekly irinotecan/carboplatin (IC) or weekly paclitaxel/carboplatin (PC) with concurrent thoracic radiotherapy (TRT) for unresectable stage III non-small-cell lung cancer (NSCLC): WJTOG0105

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000283204.17566.c5 ◽

2007 ◽

Vol 2 (8) ◽

pp. S365-S366 ◽

Author(s):

Kimihide Yoshida ◽

Hisao Uejima ◽

Miyako Satouchi ◽

Shinzoh Kudoh ◽

Kazuhiko Nakagawa ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Stage Iii ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Unresectable Stage ◽

Phase Iii Study

Download Full-text

MA07.03 Alectinib (ALC) versus Crizotinib (CRZ) in ALK-Positive Non-Small Cell Lung Cancer (ALK+ NSCLC): Primary Results from Phase III Study (J-ALEX)

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.11.427 ◽

2017 ◽

Vol 12 (1) ◽

pp. S378-S379 ◽

Author(s):

Young Kim ◽

Toyoaki Hida ◽

Hiroshi Nokihara ◽

Masashi Kondo ◽

Koichi Azuma ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study ◽

Download Full-text

138PD_PR Patient-reported outcomes (PROs) in ALEX: A phase III study of alectinib (ALEC) vs crizotinib (CRIZ) in non-small-cell lung cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(18)30412-x ◽

2018 ◽

Vol 13 (4) ◽

pp. S80-S81 ◽

Author(s):

M. Perol ◽

S. Peters ◽

N. Pavlakis ◽

E. Levchenko ◽

M. Platania ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Patient Reported Outcomes ◽

Phase Iii ◽

Small Cell Lung ◽

Patient Reported ◽

Phase Iii Study

Download Full-text

O-101 XYOTAX™/carboplatin vs paclitaxel/carboplatin for the treatmentof PS2 patients with chemotherapy-naïve advanced non-small cell lung cancer (NSCLC): The stellar 3 phase III study

Lung Cancer ◽

10.1016/s0169-5002(05)80235-1 ◽

2005 ◽

Vol 49 ◽

pp. S36 ◽

Author(s):

C. Langer ◽

K. O'Byrne ◽

H. Ross ◽

M. Socinski ◽

A. Szczesna ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

58 GLOB 2: a randomised phase III study comparing doublets including navelbineâ (NVB) with either gemcitabine (GEM) or carboplatin (C) in inoperable non-small-cell lung cancer (NSCLC) patients

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90093-0 ◽

2003 ◽

Vol 1 (5) ◽

pp. S22

Author(s):

E.H. Tan ◽

R. Abratt ◽

M. Krzakowski ◽

U. Gatzemeier ◽

K. Mattson ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study ◽

Download Full-text